A Swedish investor is pressing the world’s biggest drug companies to be transparent about their supply chains, after it alleged that some suppliers to those firms were dumping toxic waste into the environment.

Nordea Asset Management, the investment arm of the Nordic region’s largest bank, manages roughly $300 billion in investments, of which $6 billion is spread across Big Pharma companies. Last week it wrote to the 27 drug makers in which it is an investor demanding they publicly report who their suppliers are and how they...  